In Vitro Diagnostic Companies Analysis

Pharma Business Daily
Claim your FREE trial subscription!

Medical Devices:

In Vitro Diagnostic Companies Analysis

Espicom Business Intelligence
Market Briefing October 2006

This new report from Espicom provides an evaluation of the products, alliances and performance of over 30 leading global players. Evaluation of the products, alliances and performance of over 30 leading global players.
HUGE POTENTIAL
The global market for in vitro diagnostics (IVD) in 2007 is estimated to be US$34 billion and we expect growth to be around 9% annually.

Although in vitro diagnostics influence more than 60% of clinical decisions, IVD sales represent only a small proportion of total healthcare expenditures; in 2005 IVD sales in Europe totalled less that 2% of total healthcare expenditure. However, clinicians are under increasing pressure for better clinical outcomes and to control cost through efficient disease management. The early detection and treatment of long-term conditions is critical, and modern, fast and effective diagnostics are essential to meeting these aims.

INNOVATION IS DRIVING CHANGE
For example, molecular diagnostics is the fastest growing segment of clinical diagnostics with a growth rate of around 10-15% and is estimated to be worth approximately US$2.4 billion.

By detecting DNA and RNA sequences characteristic of bacteria, viruses or cells, molecular diagnostics has applications in a wide variety of disorders including infectious diseases, cancer and cardiovascular. Molecular diagnostic testing is often complex and usually carried out in a lab environment. The trend and challenge is to create testing products which provide fast and accurate results in a clinical setting.

This is a competitively hot area with Beckman Coulter, Becton Dickinson, Siemens, bioMérieux, Roche and Gen-Probe all involved.

For Each Company

Overview
Products/Technologies
Major Developments
Mergers, acquisitions and
alliances
Financial Performance
(where available)

All major IVD sectors
are covered

Clinical Chemistry
Immunochemistry
Haematology/Haemostasis
Microbiology
Molecular Diagnostics
Point of Care

Leading manufacturers evaluated

Abbott Diagnostics
Acolyte Biomedica
Adaltis
Axis-Shield
ARKRAY
Beckman Coulter
Becton Dickinson
BioMedica Diagnostics
bioMérieux
Bio-Rad
Biosite
Cytyc
Dade Behring
Dako
DiagnoCure
DiaMed
Fujirebio Diagnostics
Genomic Health
Gen-Probe
Genzyme Diagnostics
Hitachi Chemical Diagnostics
Inverness Medical Innovations
Luminex
Microbionix
Mikrogen
Olympus
Orion Diagnostica
Ortho-Clinical Diagnostics
Radiometer
Roche Diagnostics
Siemens Medical Solutions
Sysmex
TREK Diagnostics
Veridex

Number of pages - 166

For full details, please email keithw@cmsinfo.com

Order Form

CMS, P&A House, Alma Road, Chesham, Bucks. HP5 3HB, UK
Tel: +44 (0)1494 771734
Fax: +44 (0)1494 778994
e-mail: Jennifer Cowlard

For more information about us, visit CMSinfo.